Stephen Mullennix is COO at UroGen Pharma Ltd. (URGN). They have made 7 open-market trades across 1 company since 2019, most recently 2020-04-27.
CIK 0001764139
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| URGN | 10,084 | $348K |
Shares reported on the most recent Form 4, priced at the 2020-04-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| URGN | SELL | 2020-04-27 | 2020-04-28 | $24.35 | $4K | -11.3% | -9.9% | -10.5% |
| URGN | SELL | 2020-02-14 | 2020-02-18 | $28.04 | $17K | -9.1% | -51.8% | -15.4% |
| URGN | SELL | 2020-01-27 | 2020-01-28 | $29.26 | $20K | -1.9% | -11.1% | -18.0% |
| URGN | SELL | 2019-11-14 | 2019-11-18 | $26.00 | $16K | +18.8% | +27.0% | +12.2% |
| URGN | SELL | 2019-08-15 | 2019-08-16 | $31.65 | $19K | -5.3% | +9.6% | -20.0% |
| URGN | SELL | 2019-05-14 | 2019-05-16 | $37.98 | $23K | -9.6% | -7.8% | -16.0% |
| URGN | SELL | 2019-02-14 | 2019-03-07 | $37.30 | $209K | +6.5% | +12.1% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.